Anheuser-Busch InBev's Mexican arm Grupo Modelo sued U.S. firm Constellation Brands for breaching a deal on the use of the Corona brand name by applying it to a non-beer product.
Constellation has used the name for sparkling water with alcohol and flavoring dubbed Corona Hard Seltzer, one of the very popular seltzer drinks in the US.
The suit was filed in the US district court of the southern district of New York on Monday after AB InBev was unable to settle the matter directly with Constellation.
When AB InBev took full control of Grupo Modelo in 2013, it sold Grupo Modelo’s business in the US to Constellation, including the Corona brand.
But the licensing arrangement for Corona was only for beer and not for hard seltzer.
AB InBev kept rights to the Modelo brands, including Corona, in Mexico and elsewhere.
Constellation said it had “fully and completely” complied with the terms of the sub-license agreement and would vigorously defend its rights. It added that Modelo’s claims that its seltzer should not be classified as a beer were without merit and an attempt to restrain a strong competitor.
Constellation launched Corona Hard Seltzer in February 2020 and said in October the brand had a 6% share of the U.S. seltzer market, making it the fourth-biggest brand in the segment.


Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
REPAY Stock Rises After Visa Platform Connect Collaboration
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows 



